15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Cameco Corp, 7 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $102.00 to $175.00, a moderate spread. The average target of $133.78 sits 54% above the current $86.97. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.35 next quarter toward $2.69 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy778%
Hold222%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Cameco Corp.
As of Jul, 7 of 9 firms rate CCJ a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CCJ EPS & revenue forecast
EPS · NEXT QUARTER
$0.35
Range $0.10 – $0.58 · 9 analysts · +403% YoY
Next period, 9 analysts expect Cameco Corp to earn $0.35 a share (range $0.10 – $0.58), versus $0.07 a year earlier. Full-year consensus is $1.67, growing to $2.69 the year after.
REVENUE · NEXT QUARTER
$718.0M
Range $620.1M – $824.5M · 9 analysts · +17% YoY
Revenue is expected to reach $718.0M (range $620.1M – $824.5M), +16.8% year-over-year. Full-year consensus is $3.5B, rising to $4.0B next year.
Top analysts covering Cameco Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CCJ.
#1
AW
Andrew Wong
RBC Capital
Buy
$175.00+101.2% to target
Coverage
—
+ Follow
#2
BL
Brian Lee
Goldman Sachs
Buy
$133.00+52.9% to target
Coverage
—
+ Follow
#3
GL
Gordon L. Johnson
GLJ Research
Buy
$152.60+75.5% to target
Coverage
—
+ Follow
#4
RG
Richard Garchitorena
Barclays
Hold
$104.00+19.6% to target
Coverage
—
+ Follow
#5
GE
George Eadie
UBS
Hold
$166.00+90.9% to target
Coverage
—
+ Follow
CCJ stock forecast FAQ
What is CCJ's average 12-month price target?+
The 8 analysts with a live target average $133.78 for Cameco Corp over the next 12 months, ranging from a $175.00 high to a $102.00 low.
Is CCJ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 7 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CCJ?+
The Street-high target is $175.00 (RBC Capital), and the Street-low is $102.00 (CLSA). The average of all 8 active targets is $133.78.
How many Wall Street analysts cover CCJ?+
9 analysts have an active rating on Cameco Corp, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering CCJ?+
Among analysts who currently cover CCJ, Andrew Wong of RBC Capital has the strongest overall Quantellect track record. Their current call is Buy with a $175.00 target.
What is Cameco Corp's projected EPS for next quarter?+
The consensus estimate is $0.35 per share (range $0.10 – $0.58) across 9 analysts. Full-year EPS is projected at $1.67, rising to $2.69 the following year.
How much revenue is Cameco Corp expected to report next quarter?+
Consensus revenue is $718.0M (range $620.1M – $824.5M). Full-year revenue is projected at $3.5B, growing to $4.0B next year.
Have analysts been upgrading or downgrading CCJ lately?+
As of Jul, 7 of 9 firms rate CCJ a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CCJ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Truist Securities
